Literature DB >> 31656908

Investigations into the Influence of Solvents on the Nucleation Kinetics for Isonicotinamide, Lovastatin, and Phenacetin.

Lie-Ding Shiau1,2.   

Abstract

A new method of data interpretation based on classical nucleation theory is proposed in this work to elucidate the influence of solvents on the pre-exponential nucleation factor and interfacial energy using the induction time data for three crystallization systems, including isonicotinamide, lovastatin, and phenacetin. In this method, the pre-exponential nucleation factor is replaced by the intrinsic nucleation factor multiplied by temperature and divided by solution viscosity. The proposed method is applied to study the nucleation kinetics of isonicotinamide, lovastatin, and phenacetin among various solvents using the induction time data measured in this work. The results indicate that the intrinsic nucleation factor increases linearly with increasing square root of interfacial energy in various solvents for each system.
Copyright © 2019 American Chemical Society.

Entities:  

Year:  2019        PMID: 31656908      PMCID: PMC6811862          DOI: 10.1021/acsomega.9b02102

Source DB:  PubMed          Journal:  ACS Omega        ISSN: 2470-1343


Introduction

Nucleation is the initial process for the formation of crystals in solutions. In classical nucleation theory (CNT),[1−3] the nucleation rate is expressed in the thermally activated Arrhenius form governed by the pre-exponential nucleation factor and interfacial energy. The interfacial energy is the energy required to create a new solid liquid interface for the formation of crystals in solutions. Traditionally, the interfacial energy is determined from the induction time measurements by assuming J ∝ ti–1.[1,4−7] Generally, the higher the value of interfacial energy, the more difficult it is for the solute to crystallize. As the nucleation behavior of the same solute is greatly influenced by the choice of solvent, the study of nucleation in various solvents has long been an important research subject.[8−14] Recent studies have indicated an increasing trend of the interfacial energy with the increasing corresponding solute–solvent interaction for the same solute in various solvents.[15−18] Apart from the interfacial energy, nucleation should also be influenced by the pre-exponential factor based on CNT. However, few studies have been published regarding to the influence of the solvent type on the pre-exponential factor for nucleation. Although the pre-exponential factor is related to the solute mobility in solutions, it is also implicitly dependent on the interfacial energy of a crystalline solid according to the derivation of CNT,[2,3,19] which nevertheless has not been experimentally validated in the literature. Nucleation in various solvents for a system can provide important information for nucleation rate parameters. In this work, the influence of the solvent type on nucleation will be investigated based on CNT to examine the implicit relationship between the pre-exponential factor and interfacial energy in various solvents using the induction time data for three common model compounds widely studied in crystal engineering, including isonicotinamide, lovastatin, and phenacetin. The chemical structures of these compounds are given in Figure . Various common crystal structures of these compounds have been reported in the literature.[20−23]
Figure 1

Chemical structures of (a) isonicotinamide, (b) lovastatin, and (c) phenacetin.

Chemical structures of (a) isonicotinamide, (b) lovastatin, and (c) phenacetin.

Theory

The nucleation rate based on CNT is expressed as[1−3]where AJ is the nucleation pre-exponential factor, γ is the interfacial energy, kB is the Boltzmann constant, is the molecular volume, and S = C0/Ceq is the supersaturation ratio. As the solute attachment for small critical nucleus in a stirred solution should be interface-transfer control, it yields based on CNT[2,3,19]where DAB is the solute diffusivity in the solution. For simplicity, the solute diffusivity is usually estimated based on the Stokes–Einstein equation as[1]where r0 is the molecular radius of solute and η is the solution viscosity. As DAB is generally assumed to be proportional to T/η(T,S) for the same solute among various solvents,[10,13,19]eq becomes To differentiate between the effects of γ1/2 and T/η(T,S) on AJ, the intrinsic nucleation factor A0 is introduced in this work as[24] Substituting eq into eq yields Consequently, although AJ in eq is dependent on DAB among various solvents, A0 is not related to the dependence of DAB on T/η(T,S) among various solvents. Substituting eq into eq yields Thus, J is expressed in terms of A0 and γ, as opposed to J commonly adopted in terms of AJ and γ in eq . In the induction time study, the nucleation event is usually assumed to correspond to a point at which the total number density of accumulated crystals in a vessel has reached a fixed (but unknown) value, f.[25−28] Thus, one obtains at the nucleation time tiwhere f depends on the measurement device and on the substance. Note that eq is consistent with J ∝ ti–1 reported in the literature.[1] Based on the study of 28 systems, Mersmann and Bartosch[29] estimated fV = 10–4 to 10–3 with a detectable size of 10 μm. If the intermediate value, fV = 4 × 10–4, for spherical nuclei with kV = π/6 is assumed, it leads to f = 7.64 × 1011 m–3 proposed by Shiau.[24] Substituting eq into eq yields Experimental induction time data can be evaluated by plotting ln(1/ti) versus 1/T3 ln2S for determination of γ from the slope and AJ from the intercept, respectively. Substituting eq into eq yields Experimental induction time data can be evaluated by plotting ln[η(T,S)/tiT] versus 1/T3 ln2S for determination of γ from the slope and A0 from the intercept, respectively.

Results and Discussion

Tables –3 list the experimental average induction time data of each solute in various solvents measured for various S at the specified temperature for three crystallization systems, including isonicotinamide, lovastatin, and phenacetin. The induction time measurements under each condition are repeated three times, and the deviation of the induction time is generally less than 15%. In the following, eqs and 10 are applied to determine the nucleation kinetics in various solvents using the induction time data for each system.
Table 1

Experimental Induction Time Data of Isonicotinamide in Each Solvent for Various S at 303 K

solutesolventS (-)ti (s)
isonicotinamidemethanol1.43664
  1.45564
  1.50400
  1.55370
 acetone1.201077
  1.25330
  1.30186
  1.40122
 acetonitrile1.102879
  1.131338
  1.14787
  1.20206
 ethyl acetate1.051156
  1.07605
  1.10589
  1.15341
Table 3

Experimental Induction Time Data of Phenacetin in Each Solvent for Various S at 298 K

solutesolventS (-)ti (s)
phenacetinethanol1.103507
  1.151223
  1.18638
  1.20530
 acetonitrile1.043602
  1.07842
  1.10377
  1.113279
 ethyl acetate1.051799
  1.071114
  1.09737
  1.12504
In the application of eq , the solution viscosities η(T,S) in various solvents for each system are experimentally measured in this work using a rotational viscometer (Brookfield DV2T). The measurements under each condition are repeated three times, and the deviation of the viscosity value is generally less than 6%. Figure a shows the measured supersaturation dependence of solution viscosity for isonicotinamide in various solvents at 303 K, where Ceq for isonicotinamide in each solvent at 303 K is taken from a report by Hansen et al.[22] (Ceq = 210 mg solute/g solvent for methanol, Ceq = 11 mg solute/g solvent for ethyl acetate, Ceq = 23 mg solute/g solvent for acetonitrile, and Ceq = 37 mg solute/g solvent for acetone). Figure b shows the measured induction time data fitted to eq for isonicotinamide in various solvents at 303 K, where the induction time data are experimentally obtained in this work for various initial concentrations cooled to 303 K. Figure c shows that A0 increases linearly with increasing γ1/2 for isonicotinamide in various solvents at 303 K, where A0 and γ in each solvent are determined using the corresponding induction time data fitted to eq . On the other hand, Figure d shows that no clear relationship is observed between AJ and γ1/2 for isonicotinamide in various solvents at 303 K, where AJ and γ in each solvent are determined using the corresponding induction time data fitted to eq .
Figure 2

Isonicotinamide in various solvents: (a) dependence of η on supersaturation at 303 K; (b) induction time data fitted to eq at 303 K; (c) linear relationship between A0 and γ1/2 at 303 K; and (d) AJ vs γ1/2 at 303 K.

Isonicotinamide in various solvents: (a) dependence of η on supersaturation at 303 K; (b) induction time data fitted to eq at 303 K; (c) linear relationship between A0 and γ1/2 at 303 K; and (d) AJ vs γ1/2 at 303 K. As shown in Figure a, η increases in the order: acetone < acetonitrile < ethyl acetate < methanol. Although Figure c shows that A0 increases in the order: ethyl acetate < acetonitrile < acetone < methanol, AJ in Figure d increases in the order: ethyl acetate < methanol < acetonitrile < acetone, which is different from the increasing order of A0. It should be noted that η in methanol is significantly greater than that in other solvents. Consequently, although A0 in methanol is the greatest among various solvents, AJ in methanol becomes smaller than that in acetone or acetonitrile because of eq . Figure a shows the measured supersaturation dependence of solution viscosity for lovastatin in various solvents at 303 K, where Ceq for lovastatin in each solvent at 303 K is taken from a report by Sun et al.[30] (Ceq = 38 mg solute/g solvent for ethanol, Ceq = 22 mg solute/g solvent for butyl acetate, Ceq = 52 mg solute/g solvent for methanol, Ceq = 31 mg solute/g solvent for ethyl acetate, and Ceq = 105 mg solute/g solvent for acetone). Figure b shows the measured induction time data fitted to eq for lovastatin in various solvents at 303 K, where the induction time data are experimentally obtained in this work for various initial concentrations cooled to 303 K. Figure c shows that A0 increases linearly with increasing γ1/2 for lovastatin in various solvents at 303 K, where A0 and γ in each solvent are determined using the corresponding induction time data fitted to eq . On the other hand, Figure d shows that no clear relationship is observed between AJ and γ1/2 for lovastatin in various solvents at 303 K, where AJ and γ in each solvent are determined using the corresponding induction time data fitted to eq .
Figure 3

Lovastatin in various solvents: (a) dependence of η on supersaturation at 303 K; (b) induction time data fitted to eq at 303 K; (c) linear relationship between A0 and γ1/2 at 303 K; and (d) AJ vs γ1/2 at 303 K.

Lovastatin in various solvents: (a) dependence of η on supersaturation at 303 K; (b) induction time data fitted to eq at 303 K; (c) linear relationship between A0 and γ1/2 at 303 K; and (d) AJ vs γ1/2 at 303 K. Figure a shows the measured supersaturation dependence of solution viscosity for phenacetin in various solvents at 298 K, where Ceq for phenacetin in each solvent at 298 K is taken from a report by Croker et al.[21] (Ceq = 72 mg solute/g solvent for ethanol, Ceq = 24 mg solute/g solvent for ethyl acetate, and Ceq = 48 mg solute/g solvent for acetonitrile). Figure b shows the measured induction time data fitted to eq for phenacetin in various solvents at 298 K, where the induction time data are experimentally obtained in this work for various initial concentrations cooled to 298 K. Figure c shows that A0 increases linearly with increasing γ1/2 for phenacetin in various solvents at 298 K, where A0 and γ in each solvent are determined using the corresponding induction time data fitted to eq . On the other hand, Figure d shows that no clear relationship is observed between AJ and γ1/2 for phenacetin in various solvents at 298 K, where AJ and γ in each solvent are determined using the corresponding induction time data fitted to eq .
Figure 4

Phenacetin in various solvents: (a) dependence of η on supersaturation at 298 K; (b) induction time data fitted to eq at 298 K; (c) linear relationship between A0 and γ1/2 at 298 K; and (d) AJ vs γ1/2 at 298 K.

Phenacetin in various solvents: (a) dependence of η on supersaturation at 298 K; (b) induction time data fitted to eq at 298 K; (c) linear relationship between A0 and γ1/2 at 298 K; and (d) AJ vs γ1/2 at 298 K. As shown in Figures a,3a, and 4a, the supersaturation dependence of solution viscosity in these systems is nearly negligible because of the narrow concentration range associated with the varied supersaturations. Table lists the value of γ and the correlation coefficient R2 for each line in Figures b, 3b, and 4b. The value of γ in each solvent for these systems agrees with the reported literature value.[27,28] Note that the correlation coefficient in each solvent for these systems exceeds the critical value of 0.900 for the 90% confidence interval and 4 points (i.e., degree of freedom = 2).
Table 4

Value of γ and the Correlation Coefficient for Each Line in Figures b, 3b, and 4b

solutesolventγ (mJ/m2)R2 (-)
isonicotinamidemethanol3.320.973
 acetone2.530.992
 acetonitrile1.720.951
 ethyl acetate0.770.900
lovastatinethyl acetate1.940.915
 ethanol1.720.959
 butyl acetate1.620.974
 methanol1.440.926
 acetone1.080.965
phenacetinethanol1.170.964
 acetonitrile0.6740.960
 ethyl acetate0.6320.943
Table lists comparison between the correlation coefficient for each line in Figures c, 3c, and 4c and the corresponding critical value based on the 95% confidence interval. As the correlation coefficient for these systems exceeds the corresponding critical value based on the 95% confidence interval, it is concluded that A0 increases linearly with increasing γ1/2 in various solvents for each system. As an increasing trend of the interfacial energy with the increasing corresponding solute–solvent interaction for the same solute in various solvents has been reported in the literature,[15−18] it is speculated that the effect of this interaction on γ is also strongly correlated with that on A0 for the same system. Consequently, if the choice of solvent results in a greater γ because of a stronger solute–solvent interaction, it simultaneously results in a greater A0. On the other hand, if the choice of solvent results in a smaller γ because of a weaker solute–solvent interaction, it simultaneously results in a smaller A0.
Table 5

Comparison between the Correlation Coefficient for Each Line in Figures c, 3c, and 4c and the Corresponding Critical Value Based on 95% Confidence Interval

solutenumber of solvents (-)degree of freedom (-)acritical value (-)R2 (-)
isonicotinamide420.9500.957
lovastatin530.8780.986
phenacetin310.9970.997

Degree of freedom = number of solvents – 2.

Degree of freedom = number of solvents – 2.

Conclusions

According to CNT, is proposed in this work. Equation is derived to investigate the nucleation kinetics in various solvents using the induction time data for isonicotinamide, lovastatin, and phenacetin. Although no clear relationship is observed between AJ and γ1/2 among various solvents for each system, A0 increases linearly with increasing γ1/2 among various solvents for each system, which is consistent with eq derived based on CNT. Based on the analyzed results of nucleation kinetics in these systems, it is proposed that AJ consists of two parts: the first part T/η is proportional to DAB, and the other part A0 is proportional to γ1/2. Although AJ is dependent on DAB among various solvents, A0 is not related to the dependence of DAB on T/η(T,S) among various solvents. It is speculated that both γ and A0 are proportional to the solute–solvent interaction for the corresponding solvent.

Experimental Section

The experimental apparatus consists of a 250 mL crystallizer immersed in a programmable thermostatic water bath shown in Figure . The crystallizer is equipped with a magnetic stirrer at a constant stirring rate 350 rpm. The turbidity probe (Crystal Eyes manufactured by HEL limited) is used to detect the nucleation event during the induction time study.
Figure 5

Schematic diagram of the experimental apparatus: (1) 250 mL crystallizer, (2) magnetic stirrer, (3) constant temperature water bath, (4) turbidity probe, (5) temperature probe, and (6) computer.

Schematic diagram of the experimental apparatus: (1) 250 mL crystallizer, (2) magnetic stirrer, (3) constant temperature water bath, (4) turbidity probe, (5) temperature probe, and (6) computer. The induction times for three crystallization systems, including isonicotinamide (Alfa Aesar, purity 99%), lovastatin (Acros, purity 98%), and phenacetin (Acros, purity 78%) are measured in this work. Analytical grade solvents (purity 99.9%) are used to prepare the supersaturated solution. In each experiment, a 200 mL solution with the desired supersaturation is loaded into the crystallizer. The solution is held at 3 °C above the saturated temperature for 5–10 min to ensure a complete dissolution at the beginning of the experiment, which is also confirmed by the turbidity measurement. Then, the supersaturated solution is rapidly cooled to the desired temperature for the induction time measurements.
Table 2

Experimental Induction Time Data of Lovastatin in Each Solvent for Various S at 303 K

solutesolventS (-)ti (s)
lovastatinethyl acetate1.451139
  1.50970
  1.60573
  1.70275
 ethanol1.401998
  1.501240
  1.70633
  1.90357
 butyl acetate1.401156
  1.45788
  1.50531
  1.70363
 methanol1.301389
  1.40889
  1.50378
  1.70278
 acetone1.25846
  1.30545
  1.40447
  1.50321
  3 in total

1.  Investigating the role of solvent-solute interaction in crystal nucleation of salicylic acid from organic solvents.

Authors:  Dikshitkumar Khamar; Jacek Zeglinski; Donal Mealey; Åke C Rasmuson
Journal:  J Am Chem Soc       Date:  2014-08-08       Impact factor: 15.419

2.  Influence of solvent on crystal nucleation of risperidone.

Authors:  Donal Mealey; Jacek Zeglinski; Dikshitkumar Khamar; Åke C Rasmuson
Journal:  Faraday Discuss       Date:  2015-04-17       Impact factor: 4.008

3.  Habit Modification of the Active Pharmaceutical Ingredient Lovastatin Through a Predictive Solvent Selection Approach.

Authors:  Thomas D Turner; Lauren E Hatcher; Chick C Wilson; Kevin J Roberts
Journal:  J Pharm Sci       Date:  2018-12-24       Impact factor: 3.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.